AsymBio Kicks Off Construction of Fengxian R D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem
- Written by PR Newswire
 |
SHANGHAI, July 27, 2026 /PRNewswire/ -- AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), today announced that construction of its new R&D building has officially broken ground at the Shanghai Fengxian site. The project...
